FBT
First Trust NYSE Arca Biotechnology Index Fund · Financial Services · Asset Management
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 55 | +3 | 6.32M | $1.57B | +6 | −3 |
| Q1 2026 | 53 | +1 | 6.45M | $1.30B | +5 | −4 |
| Q4 2025 | 52 | -1 | 2.29M | $468.41M | — | −1 |
| Q3 2025 | 7 | 0 | 410.81K | $73.65M | — | — |
| Q2 2025 | 4 | 0 | 21.66K | $3.49M | — | — |
| Q1 2025 | 2 | 0 | 75.32K | $12.81M | — | — |
| Q4 2024 | 2 | 0 | 64.01K | $10.64M | — | — |
| Q3 2024 | 2 | -1 | 34.24K | $5.89M | — | −1 |
| Q2 2024 | 3 | — | 35.30K | $5.44M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Two Sigma Investments ✦ | 47.80K | +179.8% | $8.13M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 27.52K | -41.4% | $4.68M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 302 holders, 8.16M shares, $1.61B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.